Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVela Technologies Regulatory News (VELA)

Share Price Information for Vela Technologies (VELA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0125
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.001 (8.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0125
VELA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on investment in Revolve Performance

6 Jun 2016 07:00

RNS Number : 2244A
Vela Technologies PLC
06 June 2016
 

06 June 2016

 

Vela Technologies plc

 

("Vela" or the "Company")

Update on investment in Revolve Performance Limited

The Board of Vela Technologies plc (AIM: VELA), the investing company focused on early-stage and pre-IPO disruptive technology investments, announces that Revolve Performance Limited ("Revolve"), one of Vela's portfolio companies, has provided the board of Vela with an update on Revolve's recent trading performance. In June 2015 Vela invested £50,000 in Revolve and holds a minority interest in the share capital of Revolve.

Revolve is an automotive engineering business that also owns a leading performance parts brand, Mountune. Mountune's products are used by consumers and racing teams to enhance engine performance. The company has exclusive rights to supply branded and warranted performance parts through the Ford Dealership networks in the UK and US.

In June 2015 Rockpool Investors provided a growth loan of £1.5 million to Revolve and equity funding of £1.5 million in EIS qualifying shares. Vela invested £50,000 in the equity funding round.

In the year to 31 December 2015 sales for Revolve increased by 6% to £8.5 million and EBITDA increased by 9% to £530,000. EBITDA was lower than expected due to sales growth being slower than planned.

In the three months to 31 March 2016 sales were £2.8 million which were 44% ahead of the comparative period in 2015, with a particularly strong contribution from Mountune in the US. In the three months to 31 March 2016 EBITDA was £229,000, 8% ahead of the comparative period in 2015.

These financials are based on Revolve's unaudited management accounts with final audited accounts for the year to 31 December 2015 expected to be available in June 2016.

The Board of Vela will announce further updates on the investment in Revolve at the appropriate time.

Antony Laiker, Executive Director of Vela, made the following statement:

"Since our investment 12 months ago, Revolve has performed and evolved broadly in line with our expectations with the Mountune US operations starting to make a material contribution to Revolve's overall business. We look forward to this trend continuing in the future with a resulting positive impact on the valuation of our investment."

 

For further information please contact:

Vela Technologies plc

 

Brent Fitzpatrick, Non-Executive Chairman

Antony Laiker, Director

 

 

Tel: +44 (0) 7802 262 443

 

Allenby Capital Limited

(Nominated Adviser)

 

Nick Athanas/Katrina Perez

 

Smaller Company Capital Limited

(Broker)

Rupert Williams/Jeremy Woodgate

 

 

 

Tel: +44 (0) 20 3328 5656

 

 

 

Tel: +44 (0) 20 3651 2910

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUFJMITMBAMBRF
Date   Source Headline
30th Apr 20245:00 pmRNSTotal Voting Rights
26th Mar 20247:00 amRNSIssue of Equity
26th Feb 20241:21 pmRNSHolding in Company
23rd Feb 202412:15 pmRNSQuarterly Investment Update
8th Jan 202411:49 amRNSHolding(s) in Company
22nd Dec 20237:00 amRNSInterim Results
13th Dec 20237:00 amRNSQuarterly Investment Update
11th Dec 20232:19 pmRNSResult of AGM
5th Dec 202311:04 amRNSHolding in Company
1st Dec 20233:02 pmRNSExercise of Put Option
17th Nov 20238:58 amRNSNotice of AGM
28th Sep 20237:00 amRNSFinal results for the year ended 31 March 2023
27th Sep 20237:00 amRNSQuarterly Investment Update
21st Sep 20239:01 amRNSUpdate re. Economic Interest in AZD1656
8th Sep 20233:18 pmRNSFurther update re. Economic Interest in AZD1656
7th Sep 20237:00 amRNSUpdate re. Economic Interest in AZD1656
5th Sep 20238:50 amRNSUpdate on investment in Tribe Technology Group
15th Aug 20237:00 amRNSUpdate re. Economic Interest in AZD1656
12th Jun 202311:11 amRNSHolding in Company
6th Jun 20237:00 amRNSQuarterly Investment Update
23rd May 202311:45 amRNSInvestment in Tribe Technology Group Limited
15th May 20231:23 pmRNSUpdate re. Economic Interest in AZD1656
20th Apr 20233:01 pmRNSOption for potential sale of interest in AZD1656
14th Mar 20232:57 pmRNSInvestment in EnSilica plc
10th Feb 20237:00 amRNSQuarterly Investment Update
20th Jan 202312:27 pmRNSInvestment in Ethernity Networks Ltd
15th Dec 20227:00 amRNSInterim Results
6th Dec 20227:00 amRNSUpdate re. investment in EnSilica
28th Nov 20227:00 amRNSFurther investment in Northcoders Group plc
9th Nov 20229:00 amRNSUpdate re. AZD1656
8th Nov 20227:00 amRNSQuarterly Investment Update
25th Oct 202212:49 pmRNSResult of AGM
20th Oct 20221:52 pmRNSHolding(s) in Company
20th Oct 20227:52 amRNSBoard Change
28th Sep 20227:00 amRNSFinal results for the year ended 31 March 2022
2nd Sep 20227:40 amRNSStrategic Update
18th Aug 20229:53 amRNSUpdate re. St George Street Capital COVID-19 trial
22nd Jul 20227:00 amRNSQuarterly Investment Update
21st Jul 20221:40 pmRNSAppointment of Non-Executive Director
11th Jul 20227:00 amRNSHolding in Company
6th Jul 202212:07 pmRNSUpdate on investment - Community Social Investment
1st Jul 20221:27 pmRNSHolding(s) in Company
23rd Jun 202212:28 pmRNSInvestment in TruSpine Technologies plc
14th Jun 202212:49 pmRNSFurther update re TruSpine Technologies plc
14th Jun 20227:00 amRNSStatement re. potential investment in TruSpine
19th May 20221:26 pmRNSUpdate re. investment in EnSilica
3rd May 20227:00 amRNSQuarterly Investment Update and Change of Broker
26th Apr 20227:00 amRNSAppointment of PR and IR Adviser
30th Mar 20221:15 pmRNSAcquisition of a 28.8% interest in Igraine plc
7th Mar 20227:15 amRNSUpdate re. St George Street Capital COVID-19 trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.